Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 22, 2020 07:00 ET | Source: Chimerix, Inc.

Chimerix Appoints Allen Melemed, M.D. as Chief Medical Officer

DURHAM, N.C., June 22, 2020 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases,...
June 18, 2020 08:00 ET | Source: Chimerix, Inc.

Chimerix to Present at H.C. Wainwright Virtual Fireside Chat Series

DURHAM, N.C., June 18, 2020 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases,...
May 28, 2020 08:00 ET | Source: Chimerix, Inc.

Chimerix to Present at Jefferies Virtual Healthcare Conference

DURHAM, N.C., May 28, 2020 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases,...
May 07, 2020 07:00 ET | Source: Chimerix, Inc.

Chimerix Reports First Quarter 2020 Financial Results and Provides Operational Update

DURHAM, N.C., May 07, 2020 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases,...
April 29, 2020 07:00 ET | Source: Chimerix, Inc.

Chimerix Announces Initiation of a Phase 2/3 Study of DSTAT in Acute Lung Injury for Patients with Severe COVID-19

FDA Clearance to Proceed with Phase 2/3 Randomized, Double-Blind, Placebo Controlled Study Mechanisms of Action May Address Overactive Inflammatory Response, Including Underlying Causes of Blood...
April 28, 2020 16:30 ET | Source: Chimerix, Inc.

Chimerix Receives FDA Clearance for Rolling Submission of New Drug Application for Brincidofovir as a Medical Countermeasure for Smallpox

DURHAM, N.C., April 28, 2020 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases,...
February 26, 2020 08:00 ET | Source: Chimerix, Inc.

Chimerix to Present at Cowen and Company 40th Annual Health Care Conference

DURHAM, N.C., Feb. 26, 2020 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases,...
February 25, 2020 07:00 ET | Source: Chimerix, Inc.

Chimerix Reports Fourth Quarter and Year End 2019 Financial Results and Provides Operational Update

- Successful DSTAT End of Phase 2 Meeting with FDA Confirms Phase 3 Readiness; First Patient Visit Expected mid-2020 in 1L AML - - Brincidofovir pre-NDA Meeting Scheduled with FDA, on Track for...
February 24, 2020 08:00 ET | Source: Chimerix, Inc.

Chimerix Appoints Pratik S. Multani, M.D., to Board of Directors

DURHAM, N.C., Feb. 24, 2020 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases,...
February 18, 2020 08:00 ET | Source: Chimerix, Inc.

Chimerix to Report Fourth Quarter and Year End 2019 Financial Results and Provide an Operational Update on February 25, 2020

DURHAM, N.C., Feb. 18, 2020 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases,...